It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COR’s FA Score shows that 4 FA rating(s) are green whileHSIC’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COR’s TA Score shows that 4 TA indicator(s) are bullish while HSIC’s TA Score has 4 bullish TA indicator(s).
COR (@Medical Distributors) experienced а +1.17% price change this week, while HSIC (@Medical Distributors) price change was +10.87% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.09%. For the same industry, the average monthly price growth was -2.27%, and the average quarterly price growth was -12.50%.
COR is expected to report earnings on Jan 30, 2025.
HSIC is expected to report earnings on Feb 12, 2025.
Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
COR | HSIC | COR / HSIC | |
Capitalization | 48.4B | 9.71B | 499% |
EBITDA | 3.71B | 877M | 423% |
Gain YTD | 20.690 | -2.615 | -791% |
P/E Ratio | 26.47 | 23.50 | 113% |
Revenue | 272B | 12.3B | 2,211% |
Total Cash | 2.87B | 171M | 1,680% |
Total Debt | 4.78B | 2.74B | 174% |
COR | HSIC | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 2 | 65 | |
SMR RATING 1..100 | 11 | 73 | |
PRICE GROWTH RATING 1..100 | 34 | 34 | |
P/E GROWTH RATING 1..100 | 29 | 23 | |
SEASONALITY SCORE 1..100 | n/a | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HSIC's Valuation (78) in the Medical Distributors industry is in the same range as COR (93) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew similarly to COR’s over the last 12 months.
COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (65) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.
COR's SMR Rating (11) in the Real Estate Investment Trusts industry is somewhat better than the same rating for HSIC (73) in the Medical Distributors industry. This means that COR’s stock grew somewhat faster than HSIC’s over the last 12 months.
COR's Price Growth Rating (34) in the Real Estate Investment Trusts industry is in the same range as HSIC (34) in the Medical Distributors industry. This means that COR’s stock grew similarly to HSIC’s over the last 12 months.
HSIC's P/E Growth Rating (23) in the Medical Distributors industry is in the same range as COR (29) in the Real Estate Investment Trusts industry. This means that HSIC’s stock grew similarly to COR’s over the last 12 months.
COR | HSIC | |
---|---|---|
RSI ODDS (%) | 1 day ago47% | N/A |
Stochastic ODDS (%) | 1 day ago60% | 2 days ago69% |
Momentum ODDS (%) | 1 day ago56% | 2 days ago58% |
MACD ODDS (%) | 1 day ago50% | 2 days ago53% |
TrendWeek ODDS (%) | 1 day ago61% | 2 days ago57% |
TrendMonth ODDS (%) | 1 day ago63% | 2 days ago51% |
Advances ODDS (%) | 1 day ago62% | 3 days ago55% |
Declines ODDS (%) | 7 days ago45% | 14 days ago55% |
BollingerBands ODDS (%) | 1 day ago55% | 2 days ago62% |
Aroon ODDS (%) | 1 day ago63% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLOV | 50.55 | 0.21 | +0.42% |
Goldman Sachs ActBt Wld Lw Vl Ps Eq ETF | |||
HSMV | 37.59 | 0.08 | +0.22% |
First Trust Horizon Managed Vol S/M ETF | |||
AMUB | 18.32 | N/A | N/A |
UBS ETRACS Alerian MLP ETN Series B | |||
TLTE | 53.72 | -0.13 | -0.23% |
FlexShares Mstar EmgMkts FctTilt ETF | |||
XLY | 214.62 | -0.95 | -0.44% |
The Consumer Discret Sel SectSPDR® ETF |
A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.
Ticker / NAME | Correlation To COR | 1D Price Change % | ||
---|---|---|---|---|
COR | 100% | +1.02% | ||
MCK - COR | 59% Loosely correlated | +1.15% | ||
CAH - COR | 54% Loosely correlated | +2.56% | ||
OMI - COR | 23% Poorly correlated | +2.86% | ||
SHTDF - COR | 17% Poorly correlated | N/A | ||
HSIC - COR | 11% Poorly correlated | +0.05% | ||
More |
A.I.dvisor indicates that over the last year, HSIC has been loosely correlated with PDCO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if HSIC jumps, then PDCO could also see price increases.
Ticker / NAME | Correlation To HSIC | 1D Price Change % | ||
---|---|---|---|---|
HSIC | 100% | -1.48% | ||
PDCO - HSIC | 55% Loosely correlated | -1.71% | ||
OMI - HSIC | 24% Poorly correlated | -4.19% | ||
CAH - HSIC | 20% Poorly correlated | +1.70% | ||
COR - HSIC | 18% Poorly correlated | +0.92% | ||
ZYXI - HSIC | 16% Poorly correlated | +0.51% | ||
More |